People With Severe Diabetes Are Cured in Small Trial of New Drug A person’s conventional supplies for treating type 1 diabetes A single infusion of a new treatment, called zimislecel, may have cured 10 out of 12 people with the most severe form of the disease
Zimislecel, a novel cell therapy, appears to restore islet . . . Treatment was administered to a specific patient population: adults with longstanding type 1 diabetes (mean age, 42 years; mostly men; all white; mean duration of diabetes, 22 years); at least two
Most T1D Patients Insulin-Free After Stem Cell Infusion . . . After a single infusion of zimislecel, all 12 participants had a clinically meaningful and marked improvements in glycemic control, including an HbA1c less than 7%, 76 1% time spent in target
People with Severe Type 1 Diabetes are Cured in Small Trial . . . "A single infusion of a stem cell-based treatment may have cured 10 out of 12 people with the most severe form of Type 1 diabetes," reports the New York Times "One year later, these 10 patients no longer need insulin The other two patients need much lower doses " The experimental treatment, cal
New Type 1 Diabetes Treatment Eliminates Need for Insulin In June, the FDA approved Lantidra—the first donor cell therapy for people with type 1 diabetes who struggle with severe and recurrent low blood sugar The drug eliminates the need for external insulin, and avoids something as invasive as an islet cell transplant
One Step Closer to a Cure: Breakthrough “Harmine Pill” Sparks . . . Researchers and bioinformaticians at the Icahn School of Medicine at Mount Sinai have unveiled new insights into the mechanisms behind human beta cell regenerative drugs, offering a potential breakthrough for the over 500 million people worldwide living with diabetes